Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Fujii

Showing results (491-500 of 518) with videos related to

Pageof 52
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 10, 2025
External validation of a flowchart related to achieving the target area under the concentration-time curve for vancomycin: A retrospective multicenter studyTomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.
Journal of Pharmaceutical Health Care and Sciences|March 13, 2025
Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced ageKeisuke Takada, Masaru Samura, Yuki Igarashi, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2026
Development of a risk prediction model for vancomycin-associated acute kidney injury: a multicentre retrospective studyTomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 4, 2023
Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective studyTomoyuki Ishigo, Satoshi Fujii, Yuta Ibe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2024
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal CancerNaoko Iida, Mitsuho Imai, Wataru Okamoto, et al.
Annals of Neurology|December 8, 2023
RNA Foci in Two bi-Allelic RFC1 Expansion CarriersTaishi Wada, Hiroshi Doi, Masaki Okubo, et al.
British Journal of Cancer|October 4, 2017
Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) studyEiji Shinozaki, Takayuki Yoshino, Kentaro Yamazaki, et al.
International Journal of Clinical Oncology|March 1, 2023
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutantChikako Nakai, Sachiyo Mimaki, Koutatsu Matsushima, et al.
Biomedical Reports|October 1, 2019
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencingSatoshi Fujii, Takayuki Yoshino, Kentaro Yamazaki, et al.
DEN Open|July 2, 2026
Evaluation of Additional Treatment for Residual Cases After Endoscopic Papillectomy of Duodenal Ampullary TumorsYusuke Kurita, Keiki Nagai, Noriki Kasuga, et al.
Pageof 52

Showing results (491-500 of 518) with videos related to

Sort By:
Pageof 52
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 10, 2025
External validation of a flowchart related to achieving the target area under the concentration-time curve for vancomycin: A retrospective multicenter studyTomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.
Journal of Pharmaceutical Health Care and Sciences|March 13, 2025
Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced ageKeisuke Takada, Masaru Samura, Yuki Igarashi, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2026
Development of a risk prediction model for vancomycin-associated acute kidney injury: a multicentre retrospective studyTomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 4, 2023
Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective studyTomoyuki Ishigo, Satoshi Fujii, Yuta Ibe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2024
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal CancerNaoko Iida, Mitsuho Imai, Wataru Okamoto, et al.
Annals of Neurology|December 8, 2023
RNA Foci in Two bi-Allelic RFC1 Expansion CarriersTaishi Wada, Hiroshi Doi, Masaki Okubo, et al.
British Journal of Cancer|October 4, 2017
Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) studyEiji Shinozaki, Takayuki Yoshino, Kentaro Yamazaki, et al.
International Journal of Clinical Oncology|March 1, 2023
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutantChikako Nakai, Sachiyo Mimaki, Koutatsu Matsushima, et al.
Biomedical Reports|October 1, 2019
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencingSatoshi Fujii, Takayuki Yoshino, Kentaro Yamazaki, et al.
DEN Open|July 2, 2026
Evaluation of Additional Treatment for Residual Cases After Endoscopic Papillectomy of Duodenal Ampullary TumorsYusuke Kurita, Keiki Nagai, Noriki Kasuga, et al.
Pageof 52